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G02-1445-A

Understanding Vaccines
This NebGuide explains the basics of vaccine value, the differences between types of vaccines used
in animals, and discusses vaccine selection and vaccination program development.
Dee Griffin, Extension Veterinarian
Steve Ensley, Diagnostic Veterinarian
Dave Smith, Extension Veterinarian; and
Grant Dewell, Clinical Veterinarian
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Vaccine Terms
Vaccine Types
What Should Be Expected From Vaccines
Factors That Influence Vaccine Selection
Why Vaccines Fail to Work

Vaccines are an important part of disease prevention and control. Like insurance, vaccines come at a
cost, including the price of the vaccine, labor to administer the vaccine, localized tissue damage from
vaccine injections, and increased metabolic demand of the animal causing potential performance loss
during the time the animal is developing a proper immune response. The increased metabolic demand
can cause the animal to look depressed and therefore may be confused with illness. This is sometimes
referred to as "vaccine sweat." If the risk of a particular disease is low, the insurance afforded by
vaccination may not be required and the benefit provided might not be cost effective. If the risk of
disease is high, the insurance afforded by vaccination may be very cost effective even if it does not
completely prevent sickness. It is important to view vaccines only as an aid to health management and
not the foundation of animal health.
Vaccine Terms
Vaccine: A preparation of a weakened or killed pathogen, such as a bacterium or virus, or of a portion
of the pathogen's structure that upon administration stimulates antibody production against the pathogen
but is incapable of causing severe infection.
Antigen: A substance that when introduced into the body stimulates the production of an antibody.
Antibody: A specific disease protection protein produced by the animal's body in response to contact
with disease causing organisms or vaccine.

Adjuvant: An immunological agent that enhances the immune response to a vaccine.
Endotoxin: A bacterial cell wall component released when bacteria die that is able to cause collapse of
several animal physiologic processes (Endotoxic Shock). Endotoxin can be a problem in poorly
manufactured killed bacterial vaccines or when multiple bacterial vaccines are given at once. Frequently
the endotoxin level in autogenous bacterial vaccines is high and therefore should be used with caution.
Ask your veterinarian for more information on this subject.
Interferon: A protein produced by cells in response to infection by a virus that acts to prevent viral
replication and have the ability to induce resistance to viral antigens.
Active immunity: Immunity produced in response to a disease organism or vaccine.
Passive immunity: Immunity, usually antibodies, acquired from colostrum or anti-toxins. Although
duration of activity is brief (weeks to months), it is critical to the health of young animals. While
present, passive immunity may interfere with the immune response to a vaccine. Colostrum provided to
infants is the most common example of acquired passive immunity.
Intramuscular (IM) Injection: An injection given in the muscle. The size (length and diameter) of the
needle used should be appropriate for the animal.
Subcutaneous (SQ) Injection: An injection given between the skin and underlying muscle. SQ is the
preferred route of administration for all vaccines given to food producing animals because of the
damage done by IM injections to edible tissue. This is especially true of killed vaccines that contain an
adjuvant such as aluminum hydroxide or oil. Because SQ injections cause less damage to muscle, it is
reasonable to think SQ administration is more humane and could improve animal performance.
Intranasal (IN) Administration: Aerosolized product delivered through the nasal cavity.
Vaccine Types (Figure 1)
Killed vaccines (KV) and toxoids are killed microorganisms, organism components or organism byproducts. KV products use a large amount of organisms and adjuvants such as aluminum hydroxide or
oil to produce a sufficient immune response. Adjuvants enhance the immune response by increasing the
stability of the vaccine in the body, which then stimulates the immune system for a longer time. The
major advantages of killed vaccines are safety and stability of the product.
Subunit vaccines are a type of killed vaccine that contains only part of the virus or other microorganism.
These vaccines were developed to either isolate or engineer the most important part of the
microorganism needed to produce a proper immune response and eliminate the part(s) of the
microorganism that caused adverse vaccine reactions or interfered with a proper immune response.
Autogenous bacterial vaccines (Autogenous Bacterins) are produced from disease causing organisms
isolated from sick animals. The disease causing bacteria are grown in culture, killed and mixed with an
adjuvant. These vaccines frequently contain high levels of endotoxin and other by-products found in the
culture (debris). Because autogenous vaccines frequently contain high levels of endotoxin and other byproducts found in the culture (debris), they should be used with caution.
Modified live vaccines (MLV) contain a small quantity of virus or bacteria that has been altered so that
it no longer is capable of causing clinical disease but is still capable of infection and multiplying in the

animal. Recognition of the replicating organism by the animal's immune system results in an enhanced
immune response. The immunity produced by MLV typically lasts longer than the immunity produced
by killed vaccines. Handling and storage of MLV products is critical. Exposure to high temperatures,
sunlight, freezing temperatures, disinfectants or soaps can damage or destroy a MLV product. MLV
products require rehydration of lyophilized vaccine cake with provided diluent and should be used
within an hour of mixing. The major advantage of modified live vaccines is a broader scope and
duration of protection because the animal is exposed to all stages of the replicating virus or bacteria.
Chemically altered vaccines contain modified live organisms that have been grown in a media
containing adjusted levels of certain chemicals that trigger and amplify mutation of the organism,
changing the organism's metabolism in such a way as to alter the ability to cause disease. Temperature
sensitive (TS) vaccine organisms are examples of an organism produced by this process. The TS
organism loses the ability to grow at the animal's normal body temperature but can grow at the
temperatures present in ocular or nasal mucosa. Chemically altered organisms are considered safer than
typical modified live organisms, but when given by a route other than direct contact with the mucus
membranes stimulate little or no local immunity. The immune response produced is similar to MLV
products but the duration of immunity is not considered to be as long. The major advantage of
chemically altered vaccines is they are safe to use with pregnant animals because there is no systemic
replication of the vaccine organism.
Figure 1. Vaccine types: advantages vs disadvantages.
Killed Vaccines (KV) and Toxoids
Disadvantages:
Advantages:
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Available for a wide variety of diseases
No risk of reverting to virulent form
No risk of vaccine organism spreading
between animals
Little risk of causing abortion
More stable in storage
No on-farm mixing, therefore less risk of
contamination
Excellent stimulant of passive antibodies in
colostrum
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More likely to cause allergic reactions and
post vaccination lumps
z Two initial doses required at least 10 days
apart
z Slower onset of immunity
z May not produce as strong or as longlasting immunity as MLV products
z Produce a narrower spectrum of protection
than MLV products
z Tend to be more expensive than MLV
products
Modified Live Vaccines (MLV)
Disadvantages:

One initial dose is usually sufficient but
additional booster doses may be required
More rapid protection than KV products
Produces a wider spectrum of protection
than KV products
Less likely to cause allergic reactions or
post vaccination lumps than KV products
Less susceptible to passive antibody vaccine
block than KV products
Tend to be less expensive
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Potential to mutate to a virulent form
Could exacerbate disease in
immunosuppressed animals
Potential for excessive immune response
Some risk of causing abortion or transient
infertility
Must be handled and mixed with additional
care

Advantages:

Chemically Altered Vaccines
Disadvantages:

Protection not as rapid as MLV products
z Two initial doses required
z
z May not produce as strong or as longlasting immunity
z
z
z Unless given on a mucus membrane,
z
stimulates little or no mucosal immunity
z Must be handled and mixed more carefully
z Tend to be more expensive than modified
live vaccines
Note: Vaccines generally are not as effective when given in the presence of passive colostrum
immunity and therefore in general, animals younger than three months of age should be revaccinated.
Visit with your veterinarian about specific questions relating to vaccination timing.
z

Share many characteristics of MLV
products
Safety similar to KV products
More rapid protection than KV products
No risk of reverting to virulent form
Little risk of causing abortion

z

What Should Be Expected From Vaccines
Vaccines should stimulate the immune system similar to a natural infection. Vaccines may not be able to
completely prevent a natural infection but the vaccine should reduce the severity or limit the frequency
of the disease. This is especially true of many bacterial diseases such as those that cause respiratory or
intestinal disease. Immunity produced by a vaccine should last long enough to protect the animal
through the typical time the animal will be exposed to the natural disease. For instance, a vaccine used to
protect an animal from a reproductive disease may not need to protect the animal longer than the typical
breeding season. Vaccines should have minimal side effects and if side effects are present, they must be
acceptable. An example of an unacceptable side effect of vaccine is the potential for abortion when used
on or in association with pregnant animals.
Lastly, the cost of vaccination should be less than the economic loss incurred by the naturally occurring
disease. The cost of vaccination should consider the long-term effects of the disease and long-term
economic losses. Vaccines should not be expected to eliminate all disease problems. Many additional
management procedures such as animal density, nutrition, environmental control, movement of animals,
levels of stress, cleanliness of the environment, cleanliness and availability of drinking water, and the
number of different disease-causing organisms in the environment can all influence how well a vaccine
will work.
Factors That Influence Vaccine Selection
Select the appropriate type of vaccine for the class of animals, their stage of production, and the disease
being considered. Vaccines can be viewed as insurance or as an investment. As an investment, consider
the cost of the disease against the cost of vaccination. Select a vaccine that will protect at a cost that will
be less than the financial loss due to the naturally occurring disease. As insurance, consider the
probability of catastrophic financial loss associated with a naturally occurring disease. In this instance,
select a vaccine that will protect the operation from catastrophic financial loss, keeping in mind the cost
of vaccination is like an insurance premium. Many combination vaccines are available for convenience.
However, combination vaccines may not always be appropriate. It may be advantageous to give BVD
and Hemophilus somnus in separate injections rather than in one combination injection. This allows the
H. somnus vaccine to be given SQ, avoiding damage to eatable tissue caused by the aluminum

hydroxide adjuvant. Vaccines are production management tools and are not a substitute for proper
animal husbandry. Production management factors need to be considered. The objective should be
disease prevention through total production management including appropriate biosecurity (Figure 2).
However, if there is a breakdown in production management and a disease outbreak occurs, the
vaccination program (insurance) needs to be adequate and effective to limit resulting losses. Thoroughly
understanding causes of vaccine failure will help prevent future problems.
Figure 2. Vaccination program development.
Reduce the risk of disease by focusing on total production management. Vaccination is only one of
the important production management strategies.
z Consult with your veterinarian to identify and
focus on disease problems

Demand a valid health certificate for all new
animal additions
z

z Isolate purchases and new additions from your
z Consult with your veterinarian about selecting
other animals for 30 days
appropriate vaccines
z Understand what can and cannot be
accomplished with vaccines

Vaccinate new additions to your herd as
directed by your veterinarian
z

z Outline a vaccination calendar for each animal
z Store and handle vaccines as recommended by
age group
the manufacturer
z Follow warnings, precautions and withdrawal
times on the vaccine label

z

z Use new sterile disposable or rinse clean
reusable syringes in boiling water

z

Select the appropriate size needle for the
animal

z

z

Record animals vaccinated, vaccines used,
vaccine lot numbers and dates
Give vaccines SQ when possible

Change needles that become damaged or
contaminated and at least between every 15 to 25
animals

Note: Some diseases are easily spread by injection needles. Visit with your veterinarian about
situations which will require the use of a sterile needle on each animal.
Why Vaccines Fail to Work
A vaccination fails when, following vaccine administration, the animals do not develop an immune
response sufficient to protect the animal from disease exposure. The immune response has two parts,
humoral (antibody protein) and cellular (circulating immune cells). When animals get sick following
vaccination, the natural inclination is to blame the vaccine. Although this is certainly an important
consideration, other factors must be evaluated to determine the cause of the failure.
Interference with a vaccine's ability to stimulate immunity is most commonly linked to pre-existing
antibody from either a previous vaccination or passively acquired antibody from colostrum. Other
causes of interference or immunosuppression include handling stress, weather stress, preexisting disease,
parasitism, malnutrition, pregnancy, and steroid treatments.
Stress can lead to immune suppression and may reduce the animal's ability to mount an immune
response. Stress could include environmental extremes, handling, inadequate nutrition, parasitism, and

other diseases. While it is common to vaccinate stressed animals, these animals are more susceptible to
adverse vaccine reactions and frequently do not develop an adequate immune response. Immune stressed
animals develop limited protection from vaccination. Frequently high stressed animals may be
incubating disease at the time of vaccination. Although the subsequent sickness and death loss mimics a
vaccine reaction, the underlying disease is to blame. Unless using the vaccine to stimulate immediate
partial immunity, delaying vaccination of stressed animals is advisable. Similarly, properly vaccinated
animals may still contract a disease if they are later stressed.
Existing antibodies to the antigen(s) contained in the vaccine can block vaccine response. Antibodies
acquired through colostrum at birth are critical to the newborn's health, but only last three to six months
and while present can block the immune response to a vaccine. This is referred to as Passive Antibody
Interference or Maternal Interference.
Improper timing of vaccination is a common cause of vaccine failure. If an animal is incubating disease
at the time of vaccination, the underlying disease may not be prevented by the vaccine. The clinical
signs may mimic an adverse vaccine reaction although the symptoms are really due to a previous
infection. An animal can succumb to a disease if exposed to the natural infection following vaccination
before it has had time to develop an adequate immune response. The protection afforded by vaccination
cannot be expected until the immune response is complete. After the first exposure to an MLV product,
interferon (a nonspecific protective protein) levels rise within hours followed by antibodies detectable in
approximately four to five days. Killed vaccine products require training the immune system by two
vaccinations given not less than 10 days apart. With KV products the immune system is not ready to
protect the animal until after a rise in antibodies following the second vaccination.
Similarly, an animal can succumb to a disease if exposed to the natural infection following vaccination
if the length of time between vaccination and exposure has been longer than the protection afforded by
the vaccine. Most vaccines do not ensure lifelong immunity from one or two injections.
The protection afforded by a vaccine may also be incomplete if the vaccine does not contain the proper
strains or serotypes of organism required to stimulate protective immunity. Although the vaccine is
administered properly and the immune system responds appropriately, the animals can still exhibit
clinical signs of the disease, particularly if the animals are stressed or exposed to an overwhelming level
of infectious agents. There are additional disease-causing organisms present in the environment that are
not commercially available in vaccines.
Vaccine may be of poor quality (low vaccine titer, contaminated, etc.). The vaccine manufacturing
industry is highly regulated by the USDA-APHIS and major manufacturers have extensive quality
control programs. Vaccine failure due to faulty vaccine manufacture is rare. USDA approved vaccines
will be safe and effective if used properly. In some situations, one type of vaccine may be better than
another. Choosing the correct vaccine and using it properly is an important part of preventative animal
health.
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